Sanofi latest IG borrower to reprice loan
French pharmaceutical company Sanofi, rated A1/AA, has amended a €7bn credit line, stretching the tenor out by a year and cutting the pricing.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
